Eduardo Bruno Martins

Eduardo Bruno Martins

Company: Sagimet Biosciences

Job title: Chief Medical Officer

Seminars:

Combination Therapy for HBV Cure 11:00 am

Chronic hepatitis B (CHB) is a major cause of liver cirrhosis, hepatocellular carcinoma and death. The WHO estimates that, in 2015, 275 million people worldwide had hepatitis B Although HBV can be efficiently suppressed with entecavir or tenofovir, most patients will need to remain on lifelong therapy, and cure remains elusive. Nevertheless, HBV suppression reduces…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.